BioCryst Pharmaceuticals, Inc. (BCRX) Social Stream



BioCryst Pharmaceuticals, Inc. (BCRX): $8.50

0.11 (+1.31%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BCRX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 388

in industry

Biocryst Pharmaceuticals Inc (BCRX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Biocryst Pharmaceuticals Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 11 $30 $12 $19.363 $16.68 16.09%
2021-12-10 11 $30 $14 $19.727 $16.68 18.27%
2021-12-13 11 $30 $14 $19.636 $16.68 17.72%
2022-01-11 11 $30 $14 $19.818 $16.68 18.81%
2022-01-26 10 $30 $14 $20 $16.68 19.9%
2022-02-23 10 $30 $14 $20.363 $16.68 22.08%
2022-02-24 10 $30 $14 $21 $16.68 25.9%
2022-02-25 10 $30 $14 $21.181 $16.68 26.98%

The Trend in the Analyst Price Target


Over the past 22 months, BCRX's average price target has gone up $12.75.

BCRX reports an average of 30.82% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-04 11 30 16 21.270 15.66 35.82%
2021-09-18 11 30 16 21.270 15.70 35.48%
2021-09-19 11 30 16 21.270 15.70 35.48%
2021-11-04 11 30 12 19.363 11.61 66.78%
2022-02-25 10 30 14 21.181 17.06 24.16%

BCRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.2 9 0 1 0 0 10

The Trend in the Broker Recommendations


Over the past 26 weeks, BCRX's average broker recommendation rating improved by 0.8.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how Biocryst Pharmaceuticals Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -854.66% of that group.
  • In the context of Pharmaceutical Products stocks, Biocryst Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 105.36% of them.
  • In the context of stocks in the mid market cap category, Biocryst Pharmaceuticals Inc's number of analysts covering the stock is greater than 903.88% of them.
  • In the context of stocks in the mid market cap category, Biocryst Pharmaceuticals Inc's average analyst price target is higher than 229.45% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Biocryst Pharmaceuticals Inc are BCAB, ALVR, and ALLO.

Is BCRX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.539 seconds.